February 25, 2026 a 01:00 pm
HSIC: Fundamental Ratio Analysis - Henry Schein, Inc.
Henry Schein, Inc., a leader in healthcare distribution, offers a robust portfolio encompassing dental, medical, and technology services globally. The company's diversified segments and strong market presence make it a resilient investment. However, market volatility and global economic conditions could impact future performance.
Fundamental Rating
The fundamental score reflects Henry Schein's strong performance in key areas, balanced by certain financial constraints.
| Category | Score | Visual Representation |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
Historical Rating
The historical data shows consistency in key performance metrics over a short span.
| Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-02-24 | 3 | 4 | 4 | 4 | 1 | 2 | 3 |
Analyst Price Targets
Analysts suggest a modest upside potential with a stable consensus.
| Metric | Value |
|---|---|
| High | $100 |
| Low | $79 |
| Median | $86.5 |
| Consensus | $87.17 |
Analyst Sentiment
The sentiment conveys a neutral outlook with a predominant hold recommendation.
| Recommendation | Count | Visual Representation |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 14 | |
| Hold | 15 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Henry Schein shows solid performance across essential metrics, echoing its strong standing in the healthcare distribution sector. While its debt strategy requires consideration, the company's diverse product lines provide a cushion. Analysts maintain a cautious outlook, which suggests stability but highlights potential limitations in aggressive growth. Investors might find value in the company's long-term resilience, balanced by volatility risks.